144 related articles for article (PubMed ID: 28445755)
21. Central domain of the human cardiac muscle ryanodine receptor does not mediate interaction with FKBP12.6.
Zissimopoulos S; Lai FA
Cell Biochem Biophys; 2005; 43(2):203-19. PubMed ID: 16049346
[TBL] [Abstract][Full Text] [Related]
22. Triadin binding to the C-terminal luminal loop of the ryanodine receptor is important for skeletal muscle excitation contraction coupling.
Goonasekera SA; Beard NA; Groom L; Kimura T; Lyfenko AD; Rosenfeld A; Marty I; Dulhunty AF; Dirksen RT
J Gen Physiol; 2007 Oct; 130(4):365-78. PubMed ID: 17846166
[TBL] [Abstract][Full Text] [Related]
23. The H29D Mutation Does Not Enhance Cytosolic Ca2+ Activation of the Cardiac Ryanodine Receptor.
Xiao Z; Guo W; Yuen SM; Wang R; Zhang L; Van Petegem F; Chen SR
PLoS One; 2015; 10(9):e0139058. PubMed ID: 26405799
[TBL] [Abstract][Full Text] [Related]
24. A new cytoplasmic interaction between junctin and ryanodine receptor Ca2+ release channels.
Li L; Mirza S; Richardson SJ; Gallant EM; Thekkedam C; Pace SM; Zorzato F; Liu D; Beard NA; Dulhunty AF
J Cell Sci; 2015 Mar; 128(5):951-63. PubMed ID: 25609705
[TBL] [Abstract][Full Text] [Related]
25. Crystal structures of wild type and disease mutant forms of the ryanodine receptor SPRY2 domain.
Lau K; Van Petegem F
Nat Commun; 2014 Nov; 5():5397. PubMed ID: 25370123
[TBL] [Abstract][Full Text] [Related]
26. An α-helical C-terminal tail segment of the skeletal L-type Ca2+ channel β1a subunit activates ryanodine receptor type 1 via a hydrophobic surface.
Karunasekara Y; Rebbeck RT; Weaver LM; Board PG; Dulhunty AF; Casarotto MG
FASEB J; 2012 Dec; 26(12):5049-59. PubMed ID: 22962299
[TBL] [Abstract][Full Text] [Related]
27. Ca
Zalk R; Marks AR
Trends Biochem Sci; 2017 Jul; 42(7):543-555. PubMed ID: 28499500
[TBL] [Abstract][Full Text] [Related]
28. The inhibitory glutathione transferase M2-2 binding site is located in divergent region 3 of the cardiac ryanodine receptor.
Liu D; Hewawasam R; Karunasekara Y; Casarotto MG; Dulhunty AF; Board PG
Biochem Pharmacol; 2012 Jun; 83(11):1523-9. PubMed ID: 22406107
[TBL] [Abstract][Full Text] [Related]
29. Divergent functional properties of ryanodine receptor types 1 and 3 expressed in a myogenic cell line.
Fessenden JD; Wang Y; Moore RA; Chen SR; Allen PD; Pessah IN
Biophys J; 2000 Nov; 79(5):2509-25. PubMed ID: 11053126
[TBL] [Abstract][Full Text] [Related]
30. Modulation of the interactions of isolated ryanodine receptors of rabbit skeletal muscle by Na+ and K+.
Hu XF; Chen KY; Xia R; Xu YH; Sun JL; Hu J; Zhu PH
Biochemistry; 2003 May; 42(18):5515-21. PubMed ID: 12731894
[TBL] [Abstract][Full Text] [Related]
31. Evidence for a role of the lumenal M3-M4 loop in skeletal muscle Ca(2+) release channel (ryanodine receptor) activity and conductance.
Gao L; Balshaw D; Xu L; Tripathy A; Xin C; Meissner G
Biophys J; 2000 Aug; 79(2):828-40. PubMed ID: 10920015
[TBL] [Abstract][Full Text] [Related]
32. The Gln4863Ala mutation within a putative, pore-lining trans-membrane helix of the cardiac ryanodine receptor channel alters both the kinetics of ryanoid interaction and the subsequent fractional conductance.
Ranatunga KM; Moreno-King TM; Tanna B; Wang R; Chen SR; Ruest L; Welch W; Williams AJ
Mol Pharmacol; 2005 Sep; 68(3):840-6. PubMed ID: 15955866
[TBL] [Abstract][Full Text] [Related]
33. Insights into the gating mechanism of the ryanodine-modified human cardiac Ca2+-release channel (ryanodine receptor 2).
Mukherjee S; Thomas NL; Williams AJ
Mol Pharmacol; 2014 Sep; 86(3):318-29. PubMed ID: 25002270
[TBL] [Abstract][Full Text] [Related]
34. Crystal structures of the N-terminal domains of cardiac and skeletal muscle ryanodine receptors: insights into disease mutations.
Lobo PA; Van Petegem F
Structure; 2009 Nov; 17(11):1505-14. PubMed ID: 19913485
[TBL] [Abstract][Full Text] [Related]
35. Structure of a mammalian ryanodine receptor.
Zalk R; Clarke OB; des Georges A; Grassucci RA; Reiken S; Mancia F; Hendrickson WA; Frank J; Marks AR
Nature; 2015 Jan; 517(7532):44-9. PubMed ID: 25470061
[TBL] [Abstract][Full Text] [Related]
36. Ryanodine receptor calcium channels and their partners as drug targets.
Mackrill JJ
Biochem Pharmacol; 2010 Jun; 79(11):1535-43. PubMed ID: 20097179
[TBL] [Abstract][Full Text] [Related]
37. Disease mutations in the ryanodine receptor central region: crystal structures of a phosphorylation hot spot domain.
Yuchi Z; Lau K; Van Petegem F
Structure; 2012 Jul; 20(7):1201-11. PubMed ID: 22705209
[TBL] [Abstract][Full Text] [Related]
38. Retina expresses a novel variant of the ryanodine receptor.
Shoshan-Barmatz V; Zakar M; Shmuelivich F; Nahon E; Vardi N
Eur J Neurosci; 2007 Dec; 26(11):3113-25. PubMed ID: 18005065
[TBL] [Abstract][Full Text] [Related]
39. Ryanodine Receptors for Drugs and Insecticides: An Overview.
Sun Z; Xu H
Mini Rev Med Chem; 2019; 19(1):22-33. PubMed ID: 29600763
[TBL] [Abstract][Full Text] [Related]
40. Calmodulin regulation and identification of calmodulin binding region of type-3 ryanodine receptor calcium release channel.
Yamaguchi N; Xu L; Pasek DA; Evans KE; Chen SR; Meissner G
Biochemistry; 2005 Nov; 44(45):15074-81. PubMed ID: 16274254
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
